This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: 23Andme, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Christine Wolak: Innovator in Asthma Treatment
Introduction
Christine Wolak is a prominent inventor based in Burlingame, CA (US). She has made significant contributions to the field of medical research, particularly in the treatment of asthma. With a total of 2 patents to her name, her work focuses on innovative methods to improve patient outcomes.
Latest Patents
Christine's latest patents include a groundbreaking method of treating asthma with anti-IL1RAP antibodies. This invention provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to human interleukin-1 receptor accessory protein (hu-IL1RAP). These proteins fully block the IL-1, IL-33, and IL-36 intracellular signaling pathways. Additionally, her patents encompass compositions comprising such binding proteins and methods of making and using them.
Career Highlights
Christine is currently employed at 23andMe, Inc., where she continues to advance her research in the field of immunology. Her innovative approach has garnered attention and respect within the scientific community.
Collaborations
Christine has collaborated with notable coworkers, including Germaine Fuh-Kelly and Quan Zheng. These partnerships have further enriched her research and contributed to her success as an inventor.
Conclusion
Christine Wolak's contributions to asthma treatment through her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile